| Message: | Pharmaceutical Raw Materials Raloxifene HCL
Product Name: Raloxifene HCL
CAS: 82640-04-8
MF: C28H28ClNO4S
MW: 510.05
Assay: 99%
Grade: Pharmaceutical Grade
Appearance: Light Yellow Powder
Usage: Pharmaceutical Raw Materials
Raloxifene (marketed as Evista) is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast cancer.
This drug is different from hormones (including estrogens and progestins). It works by acting like estrogen (as a selective estrogen receptor modulator or SERM) in some parts of the body. Raloxifene helps to preserve bone mass, but it does not affect the breast and uterus like estrogen or relieve symptoms of menopause such as hot flashes.
|
my account
